These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 11475669

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up.
    Ducloux D, Motte G, Billerey C, Bresson-Vautrin C, Vautrin P, Rebibou JM, Saint-Hillier Y, Chalopin JM.
    Transpl Int; 2002 Sep; 15(8):387-92. PubMed ID: 12221456
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity: a preliminary report.
    Ducloux D, Fournier V, Bresson-Vautrin C, Rebibou JM, Billerey C, Saint-Hillier Y, Chalopin JM.
    Transplantation; 1998 Jun 15; 65(11):1504-6. PubMed ID: 9645813
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study.
    Abramowicz D, Del Carmen Rial M, Vitko S, del Castillo D, Manas D, Lao M, Gafner N, Wijngaard P, Cyclosporine Withdrawal Study Group.
    J Am Soc Nephrol; 2005 Jul 15; 16(7):2234-40. PubMed ID: 15917338
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation - results from an aborted trial.
    Åsberg A, Apeland T, Reisaeter AV, Foss A, Leivestad T, Heldal K, Thorud LO, Eriksen BO, Hartmann A, NILS Study Group.
    Clin Transplant; 2013 Jul 15; 27(2):E151-6. PubMed ID: 23351013
    [Abstract] [Full Text] [Related]

  • 10. Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil.
    Herrero JI, Quiroga J, Sangro B, Girala M, Gómez-Manero N, Pardo F, Alvárez-Cienfuegos J, Prieto J.
    Liver Transpl Surg; 1999 Sep 15; 5(5):414-20. PubMed ID: 10477843
    [Abstract] [Full Text] [Related]

  • 11. Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China.
    Song Y, Xue W, Tian P, Ding X, Pan X, Yan H, Hou J, Feng X, Xiang H, Tian X, Qin G, Fan X.
    Eur J Clin Pharmacol; 2011 Jun 15; 67(6):553-62. PubMed ID: 21279337
    [Abstract] [Full Text] [Related]

  • 12. Introduction of mycophenolate mofetil and cyclosporin reduction in children with chronic transplant nephropathy.
    David-Neto E, Araujo LM, Lemos FC, David DS, Mazzucchi E, Nahas WC, Arap S, Ianhez LE.
    Pediatr Transplant; 2001 Aug 15; 5(4):302-9. PubMed ID: 11472611
    [Abstract] [Full Text] [Related]

  • 13. Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine.
    Aleksic I, Baryalei M, Busch T, Pieske B, Schorn B, Strauch J, Sîrbu H, Dalichau H.
    Transplantation; 2000 Apr 27; 69(8):1586-90. PubMed ID: 10836367
    [Abstract] [Full Text] [Related]

  • 14. Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction.
    Smak Gregoor PJ, van Gelder T, van Besouw NM, van der Mast BJ, IJzermans JN, Weimar W.
    Transplantation; 2000 Jul 15; 70(1):143-8. PubMed ID: 10919591
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Open randomized trial comparing early withdrawal of either cyclosporine or mycophenolate mofetil in stable renal transplant recipients initially treated with a triple drug regimen.
    Schnuelle P, van der Heide JH, Tegzess A, Verburgh CA, Paul LC, van der Woude FJ, de Fijter JW.
    J Am Soc Nephrol; 2002 Feb 15; 13(2):536-543. PubMed ID: 11805185
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.